110 related articles for article (PubMed ID: 2905770)
1. [A differential effect profile of neuroleptic therapy of acute schizophrenic patients? Results of a clinico-naturalistic study].
Schmidt LG; Siemetzki H
Nervenarzt; 1988 Dec; 59(12):721-6. PubMed ID: 2905770
[No Abstract] [Full Text] [Related]
2. [Comparison of higher-dose haloperidol therapy with perazine standard therapy in acute schizophrenic patients].
Schmidt LG; Schüssler G; Kappes CV; Müller-Oerlinghausen B
Nervenarzt; 1982 Sep; 53(9):530-6. PubMed ID: 6127637
[No Abstract] [Full Text] [Related]
3. Prediction and evaluation criteria in perazine therapy of acute schizophrenics. Methodological considerations, sample population, and research variables.
Rein W; Schied HW; Breyer-Pfaff U; Straube E
Pharmacopsychiatria; 1983 Sep; 16(5):147-51. PubMed ID: 6140693
[TBL] [Abstract][Full Text] [Related]
4. [Long-term therapy of chronic schizophrenic patients with haloperidol decanoate].
Roncoroni D
Psychiatr Prax; 1984 Mar; 11(2):56-8. PubMed ID: 6144121
[TBL] [Abstract][Full Text] [Related]
5. Predictors of neuroleptic treatment response in acute schizophrenia: results of a treatment study with perazine.
Gaebel W; Pietzcker A; Ulrich G; Schley J; Müller-Oerlinghausen B
Pharmacopsychiatry; 1988 Nov; 21(6):384-6. PubMed ID: 2907645
[No Abstract] [Full Text] [Related]
6. [Prediction of therapeutic success in acute neuroleptic treatment: results of an empirical study of 243 inpatient-treated schizophrenic patients].
Möller HJ; Scharl W; von Zerssen D
Fortschr Neurol Psychiatr; 1985 Oct; 53(10):370-83. PubMed ID: 2866152
[TBL] [Abstract][Full Text] [Related]
7. Prediction and evaluation criteria in perazine therapy of acute schizophrenics. Pharmacokinetic data.
Breyer-Pfaff U; Brinkschulte M; Rein W; Schied HW; Straube E
Pharmacopsychiatria; 1983 Sep; 16(5):160-5. PubMed ID: 6140695
[TBL] [Abstract][Full Text] [Related]
8. Can changes in eye-contacts predict therapeutic outcome in schizophrenic patients undergoing neuroleptic treatment? Results of a preliminary study.
Meya U; Renfordt E
Pharmacopsychiatry; 1986 Nov; 19(6):429-33. PubMed ID: 2879296
[TBL] [Abstract][Full Text] [Related]
9. [Neuroleptic large dose therapy of schizophrenias].
Ungvári G; Pethö B
Psychiatr Neurol Med Psychol (Leipz); 1981 Apr; 33(4):230-6. PubMed ID: 6114506
[TBL] [Abstract][Full Text] [Related]
10. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
[TBL] [Abstract][Full Text] [Related]
11. Neuroleptic levels by radioreceptor assay and clinical response during treatment of acute exacerbation of schizophrenia--some preliminary findings.
Greenberg JS; Brown WA; Laughren TP; Krantz J
Psychopharmacol Bull; 1983; 19(1):74-6. PubMed ID: 6131470
[No Abstract] [Full Text] [Related]
12. Prediction and evaluation criteria in perazine therapy of acute schizophrenics: psychopathological results.
Schied HW; Rein W; Straube E; Jung H; Breyer-Pfaff U
Pharmacopsychiatria; 1983 Sep; 16(5):152-9. PubMed ID: 6140694
[TBL] [Abstract][Full Text] [Related]
13. Initial improvement as predictor of outcome of neuroleptic treatment.
Nedopil N; Rüther E
Pharmacopsychiatria; 1981 Nov; 14(6):205-7. PubMed ID: 6119712
[TBL] [Abstract][Full Text] [Related]
14. [Changes in the health state of schizophrenic patients in neuroleptic therapy].
Heim M
Psychiatr Neurol Med Psychol (Leipz); 1986 Aug; 38(8):483-7. PubMed ID: 2878452
[TBL] [Abstract][Full Text] [Related]
15. Autonomic nervous system differences as predictors of short-term outcome in schizophrenics.
Straube ER; Schied HW; Rein W; Breyer-Pfaff U
Pharmacopsychiatry; 1987 May; 20(3):105-10. PubMed ID: 2885864
[TBL] [Abstract][Full Text] [Related]
16. Combined therapy with low-potency neuroleptic levomepromazine as an adjunct to haloperidol for agitated patients with acute exacerbation of schizophrenia.
Higashima M; Takeda T; Nagasawa T; Hirao N; Oka T; Nakamura M; Kitamura M; Koshino Y
Eur Psychiatry; 2004 Sep; 19(6):380-1. PubMed ID: 15363480
[No Abstract] [Full Text] [Related]
17. Negative correlation between alpha-1-acid-glycoprotein plasma level and response to haloperidol in the acute treatment of schizophrenia.
Levinson I; Levine S
Biol Psychiatry; 1995 Aug; 38(3):198-200. PubMed ID: 7578667
[No Abstract] [Full Text] [Related]
18. Suspension of neuroleptic therapy in acute schizophrenia.
Kuhs H; Eikelmann B
Pharmacopsychiatry; 1988 Jul; 21(4):197-202. PubMed ID: 2905064
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic efficacy of the antidepressant trimipramine: a randomized, double-blind comparison with the phenothiazine perazine.
Bender S; Olbrich HM; Fischer W; Hornstein C; Schoene W; Falkai P; Haarmann C; Berger M; Gastpar M;
Pharmacopsychiatry; 2003; 36(2):61-9. PubMed ID: 12734763
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between perazine serum concentration and clinical results in long-term treated schizophrenic outpatients (author's transl)].
Pietzcker A; Müller-Oerlinghausen B; Schley J; Chaskel H; Poppenberg A; Urban R
Arzneimittelforschung; 1978; 28(8):1302-3. PubMed ID: 37850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
